Ophthalmologic drug guide /
Rhee, Douglas J.
Ophthalmologic drug guide / Douglas J. Rhee, Kathryn A. Colby, Lucia Sobrin, Christopher J. Rapuano - Second edition - 1 online resource (138 pages) - 2011 Springer E-Books. .
Includes indexes.
Antibacterial agents -- Antifungal agents -- Antiviral agents -- Anti-parasitic agents -- Anti-glaucoma agents -- Neuro-ophthalmology -- Anti-inflammatory agents -- Mydriatics, cycloplegics, and reversal agents -- Lubricants and viscoelastics -- Miscellaneous -- Anti-angiogenesis agents -- Contact lens solutions.
The updated edition of this popular pocket guide includes new drugs available and FDA-approved since publication of the first edition and also guidance on using the growing number of drugs now prescribed for off-label purposes, such as anti-VEGF agents, used in cancer treatments, which are also being used to stop cell growth in age-related macular degeneration. Drugs are grouped by presenting disease (e.g., glaucoma, retinal disease, cataracts), and readers may also access information via the Product Index or the Subject Index. The entire book is presented in a table format to facilitate quick look-up.
9781441976215 1441976213
10.1007/978-1-4419-7621-5 doi
978-1-4419-7620-8 Springer http://www.springerlink.com
101552400 DNLM
Ophthalmic drugs
Ocular pharmacology
Eye Diseases--drug therapy
Pharmaceutical Preparations--administration & dosage
Handbooks
Handbook.
Electronic books
RE994 / .R42 2011
617.7/061
2011 D-018 WW 39
Ophthalmologic drug guide / Douglas J. Rhee, Kathryn A. Colby, Lucia Sobrin, Christopher J. Rapuano - Second edition - 1 online resource (138 pages) - 2011 Springer E-Books. .
Includes indexes.
Antibacterial agents -- Antifungal agents -- Antiviral agents -- Anti-parasitic agents -- Anti-glaucoma agents -- Neuro-ophthalmology -- Anti-inflammatory agents -- Mydriatics, cycloplegics, and reversal agents -- Lubricants and viscoelastics -- Miscellaneous -- Anti-angiogenesis agents -- Contact lens solutions.
The updated edition of this popular pocket guide includes new drugs available and FDA-approved since publication of the first edition and also guidance on using the growing number of drugs now prescribed for off-label purposes, such as anti-VEGF agents, used in cancer treatments, which are also being used to stop cell growth in age-related macular degeneration. Drugs are grouped by presenting disease (e.g., glaucoma, retinal disease, cataracts), and readers may also access information via the Product Index or the Subject Index. The entire book is presented in a table format to facilitate quick look-up.
9781441976215 1441976213
10.1007/978-1-4419-7621-5 doi
978-1-4419-7620-8 Springer http://www.springerlink.com
101552400 DNLM
Ophthalmic drugs
Ocular pharmacology
Eye Diseases--drug therapy
Pharmaceutical Preparations--administration & dosage
Handbooks
Handbook.
Electronic books
RE994 / .R42 2011
617.7/061
2011 D-018 WW 39